Barrick Niugini Limited Challenges Non-Extension of Special Mining Lease

NEXT STORY
Y-mAbs Announces Appointment of Laura J. Hamill to its Board of Directors
PREV STORY
TRACON Pharmaceuticals Retains Global Rights to TRC253 Following Completion of a Phase 1/2 Trial
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CDX-1140 Demonstrates Clinical and Biological Activity in Patients with Advanced Solid Tumors in Phase 1 Dose Escalation Study

author_avatar
NASDAQ Market News

Kinnate Biopharma Inc. in Collaboration with Guardant Health Announces Initial Findings from BRAF Kinase Alteration Genomic Landscape and Real-World Clinical Outcomes Study

author_avatar
NASDAQ Market News

Chinese Precision Medicine Market Set to Witness a Robust CAGR of 12.82% Over 2019-2029 – Cloud-Based Genomics Set to Be the Cornerstone of China’s Precision Medicine Revolution

author_avatar
NASDAQ Market News